A PCR amplicon-based SARS-CoV-2 replicon for antiviral evaluation
Sign Up to like & getrecommendations! Published in 2021 at "Scientific Reports"
DOI: 10.1038/s41598-021-82055-0
Abstract: The development of specific antiviral compounds to SARS-CoV-2 is an urgent task. One of the obstacles for the antiviral development is the requirement of biocontainment because infectious SARS-CoV-2 must be handled in a biosafety level-3… read more here.
Keywords: rna; based sars; antiviral evaluation; sars cov ... See more keywords